Lipocine doses first patient in Phase III postpartum depression study
Lipocine has dosed the first patient in its Phase III BLOOM clinical study assessing LPCN 1154 for the treatment of PPD.
The post Lipocine doses first patient in Phase III postpartum depression study appeared first on Clinical Trials Arena .